GREENLIGHT CAPITAL RE LTD-A (GLRE)

KYG4095J1094 - Common Stock

12.05  -0.1 (-0.82%)

After market: 12.05 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to GLRE. GLRE was compared to 141 industry peers in the Insurance industry. GLRE has a medium profitability rating, but doesn't score so well on its financial health evaluation. GLRE is not valued too expensively and it also shows a decent growth rate.



4

1. Profitability

1.1 Basic Checks

GLRE had positive earnings in the past year.
In the past year GLRE had a positive cash flow from operations.
GLRE had positive earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: GLRE reported negative operating cash flow in multiple years.

1.2 Ratios

GLRE has a Return On Assets of 5.01%. This is amongst the best in the industry. GLRE outperforms 82.73% of its industry peers.
The Return On Equity of GLRE (14.58%) is better than 72.66% of its industry peers.
Industry RankSector Rank
ROA 5.01%
ROE 14.58%
ROIC N/A
ROA(3y)2.61%
ROA(5y)1.57%
ROE(3y)7.77%
ROE(5y)4.66%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a decent Profit Margin value of 14.24%, GLRE is doing good in the industry, outperforming 77.70% of the companies in the same industry.
GLRE's Profit Margin has improved in the last couple of years.
GLRE has a Operating Margin of 6.26%. This is comparable to the rest of the industry: GLRE outperforms 41.73% of its industry peers.
GLRE's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.26%
PM (TTM) 14.24%
GM N/A
OM growth 3Y82.31%
OM growth 5YN/A
PM growth 3Y158.28%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

GLRE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GLRE has been increased compared to 1 year ago.
Compared to 5 years ago, GLRE has less shares outstanding
Compared to 1 year ago, GLRE has an improved debt to assets ratio.

2.2 Solvency

The Debt to FCF ratio of GLRE is 9.76, which is on the high side as it means it would take GLRE, 9.76 years of fcf income to pay off all of its debts.
GLRE has a worse Debt to FCF ratio (9.76) than 69.06% of its industry peers.
A Debt/Equity ratio of 0.12 indicates that GLRE is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.12, GLRE belongs to the best of the industry, outperforming 82.01% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF 9.76
Altman-Z N/A
ROIC/WACCN/A
WACC8.72%

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 332.73% over the past year.
Measured over the past years, GLRE shows a very strong growth in Earnings Per Share. The EPS has been growing by 151.28% on average per year.
Looking at the last year, GLRE shows a quite strong growth in Revenue. The Revenue has grown by 16.83% in the last year.
Measured over the past years, GLRE shows a very strong growth in Revenue. The Revenue has been growing by 30.32% on average per year.
EPS 1Y (TTM)332.73%
EPS 3Y151.28%
EPS 5YN/A
EPS growth Q2Q-45.05%
Revenue 1Y (TTM)16.83%
Revenue growth 3Y8.92%
Revenue growth 5Y30.32%
Revenue growth Q2Q-7.09%

3.2 Future

GLRE is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -17.19% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-18.57%
EPS Next 2Y-17.19%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

5

4. Valuation

4.1 Price/Earnings Ratio

GLRE is valuated cheaply with a Price/Earnings ratio of 5.06.
Based on the Price/Earnings ratio, GLRE is valued a bit cheaper than 79.14% of the companies in the same industry.
GLRE's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.84.
The Price/Forward Earnings ratio is 6.22, which indicates a rather cheap valuation of GLRE.
Based on the Price/Forward Earnings ratio, GLRE is valued a bit cheaper than 76.26% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.35. GLRE is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 5.06
Fwd PE 6.22

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as GLRE.
Based on the Price/Free Cash Flow ratio, GLRE is valued a bit more expensive than 70.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 56.76
EV/EBITDA 11.82

4.3 Compensation for Growth

A cheap valuation may be justified as GLRE's earnings are expected to decrease with -17.19% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-17.19%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

GLRE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

GREENLIGHT CAPITAL RE LTD-A

NASDAQ:GLRE (4/26/2024, 7:00:00 PM)

After market: 12.05 0 (0%)

12.05

-0.1 (-0.82%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap426.09M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 5.06
Fwd PE 6.22
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.01%
ROE 14.58%
ROCE
ROIC
ROICexc
ROICexgc
OM 6.26%
PM (TTM) 14.24%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0.12
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)332.73%
EPS 3Y151.28%
EPS 5Y
EPS growth Q2Q
EPS Next Y-18.57%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)16.83%
Revenue growth 3Y8.92%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y